Related Experiment Video
Updated: Oct 16, 2025
04:50
Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research
Published on: August 4, 2023
1.3K
Global Regulatory Agencies and Data Transparency.
Summary
Regulatory agencies show slow progress in data sharing. While transparency has increased over ten years, advancements by Health Canada, the European Medicines Agency, and the Food and Drug Administration remain gradual.
Area of Science:
- Pharmacovigilance
- Regulatory Science
- Data Management
Background:
- Global regulatory agencies are crucial for drug safety and efficacy.
- Data sharing practices among regulatory bodies impact public health transparency.
- Historical data sharing initiatives have aimed to improve accessibility.
Purpose of the Study:
- To review and analyze the current data sharing practices of major global regulatory agencies.
- To assess the progress in transparency of Health Canada, the European Medicines Agency, and the Food and Drug Administration over the past decade.
Main Methods:
- Comparative analysis of publicly available policies and reports.
- Review of documented data sharing initiatives and outcomes.
- Assessment of transparency trends over a ten-year period.
Main Results:
- Some progress in increasing data transparency has been observed.
- Advancements in data sharing practices across the reviewed agencies have been slow.
- Variability exists in the extent and speed of progress among the agencies.
Conclusions:
- Continued efforts are needed to accelerate data sharing and enhance transparency.
- Regulatory agencies face challenges in implementing comprehensive data sharing policies.
- Further research should explore barriers and facilitators to improved data sharing practices.
Related Concept Videos
01:28Global Regulatory Systems
182
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
182
01:03Drug Control Governance: Regulatory Bodies and Their Impact
283
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
283
01:25Drug Regulation
2.1K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.1K
01:18Healthcare Agencies I
896
Healthcare agencies provide healthcare services to people. In the United States, voluntary agencies are often non-profit centers sponsored by donations, grants, or fundraisers. One such organization is Meals on Wheels, which provides meals to the elderly and homebound. The American Heart Association and the American Lung Association are other non-profit community organizations. Doctors and nurses are frequently active members of these organizations, which offer health checks and educational...
896
01:29Translational Regulation
267
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
267
01:19Pharmacovigilance
1.1K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.1K